# Urica Therapeutics, Inc. jobs and careers

> 0 open roles at Urica Therapeutics, Inc. as of October 24, 2026. Source: https://www.thejobsmap.com/company/urica-therapeutics-inc

Urica Therapeutics, Inc. (“Urica”) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and other conditions associated with hyperuricemia. Urica acquired the rights to develop and commercialize Dotinurad, a potentially best-in-class URAT1 inhibitor, in the United States, United Kingdom, European Union, Canada, Middle East and North Africa (MENA) and Turkey from Fuji Yakuhin. Dotinurad has been approved to treat gout and hyperuricemia in Japan and is currently in a Phase 1 clinical trial in the United States. Urica was founded by Fortress Biotech, Inc. (Nasdaq: FBIO).

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Founded | 2021 |
| Employees | 1 to 10 |
| Total funding | $2.5M |
| Industries | Biotechnology, Clinical Trials, Pharmaceutical, Therapeutics |
| Website | https://uricatherapeutics.com |

## Leadership

- Jay D. Kranzler, M.D., Ph.D., Chairman and Chief Executive Officer
- Paul Brooke, Vice Chairman, Board Of Directors

## Common questions

### Is Urica Therapeutics, Inc. hiring right now?

Urica Therapeutics, Inc. has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Urica Therapeutics, Inc.'s careers site.

### Who leads Urica Therapeutics, Inc.?

Jay D. Kranzler, M.D., Ph.D., Chairman and Chief Executive Officer, is at the top of Urica Therapeutics, Inc.'s org chart.

### How do I apply for a job at Urica Therapeutics, Inc.?

Pick a role on Urica Therapeutics, Inc.'s TheJobsMap page and select Apply. Every listing links to the original posting on Urica Therapeutics, Inc.'s own careers site, so you apply directly with the employer.